Donald Vandevanter

Donald "Dutch" VanDevanter, Ph.D., is an independent consultant and an Adjunct Professor at Case Western Reserve University School of Medicine in Cleveland, OH. VanDevanter has authored over 30 peer-reviewed publications and holds a patent for pure biologically active colistin. His research and publications include CF treatment regimen changes, CF trial designs, and CF drug development and approval commentary. He has held several positions with PathoGenesis, including Program Director and Scientific Product Director, and from 2000 to early 2005, he was the Director of Medical Communications for Chiron Corporation. He graduated in 1981 from the University of Kentucky College of Arts and Sciences with a Bachelor’s of Science Magna Cum Laude in chemistry and biology, in 1983 he received a Master’s of Science in toxicology, and in 1986 he received a Ph.D. in medicinal chemistry from the University of Texas.